Completed PHASE4 INTERVENTIONAL 2-arm NCT00567983

Topical Cyclosporine and Disease Progression

Sponsor: Innovative Medical

Conditions Disease Progression Disease Severity OSDI Schirmers Staining

Updated 5 times since 2017 Last updated: Sep 23, 2008 Started: Dec 31, 2007 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00567983, this PHASE4 trial focuses on Disease Progression and Disease Severity and remains completed. Sponsored by Innovative Medical, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovative Medical

Data source: Innovative Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States